Tizanidine Tablet
Product Images NDC 60760-505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 60760-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz (Tizanidine 60760 505 15)

This is a description of Tizanidine Tablets, USP, 4mg from Lot#727277272 with an expiry date of 72-2?. The manufacturer is H/Ws&nm Limited based in Srikakulam - 532 403 India, and it was packaged by Managed Pharmacy Programs. The tablets are sold in packages of 15 with an NDC code of 60760-505-15. The tablets should be stored at a temperature ranging from 15°- 30° C (69°-86°F).*

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

The text describes the improvement in Ashworth Score during a study that involved using zanidine at a mean dose of 28.6 mg. The study had a duration of 7 weeks, and the endpoint was at the end of maintenance. The Last Observation Garred Forward method was used.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.